Adriana S Morell, Sarah E Monsell, Marie-Coralie Cornet, Jessica L Wisnowski, Robert C McKinstry, Amit M Mathur, Yi Li, Hannah C Glass, Fernando F Gonzalez, Dennis E Mayock, Kristen L Benninger, Krisa P Van Meurs, Andrea L Lampland, Tai-Wei Wu, David Riley, Ulrike Mietzsch, Lina Chalak, John Flibotte, Joern-Hendrick Weitkamp, Kaashif A Ahmad, Toby D Yanowitz, Mariana Baserga, Stephanie Merhar, Rakesh Rao, Gregory M Sokol, Bryan A Comstock, Patrick J Heagerty, Sandra E Juul, Yvonne W Wu
BACKGROUND: Infants with hypoxic ischemic encephalopathy (HIE) may have underlying conditions predisposing them to hypoxic-ischemic injury during labor and delivery. It is unclear how genetic and congenital anomalies impact outcomes of HIE. METHODS: Infants with HIE enrolled in a phase III trial underwent genetic testing when clinically indicated. Infants with known genetic or congenital anomalies were excluded. The primary outcome, i.e., death or neurodevelopmental impairment (NDI), was determined at age two years by a standardized neurological examination, Bayley Scales of Infant Development, Third Edition (BSID-III), and the Gross Motor Function Classification Scales...
February 20, 2024: Pediatric Neurology